Article content material
Corporate invitations particular person and institutional traders, in addition to advisors and analysts, to wait real-time, interactive displays on VirtualInvestorConferences.com
MONTREAL, March 06, 2023 (GLOBE NEWSWIRE) — Valeo Pharma Inc. (TSX:VPH, OTCQB: VPHIF, FSE: VP2) (“Valeo” or the “Corporate”), a Canadian pharmaceutical corporate, as of late introduced that Steve Saviuk, CEO, will provide reside on the Existence Science Investor Discussion board, hosted through VirtualInvestorConferences.com, on March 9th, 2023.
Commercial 2
Article content material
Article content material
DATE: March 9th, 2023
TIME: 11:30am
LINK:
https://bit.ly/3IoXpvP
To be had for 1×1 conferences: March 9-10, 13-14
This shall be a reside, interactive on-line match the place traders are invited to invite the corporate questions in real-time. If attendees aren’t ready to enroll in the development continue to exist the day of the convention, an archived webcast may also be made to be had after the development.
It is strongly recommended that traders pre-register and run the web machine test to expedite participation and obtain match updates.
Be informed extra concerning the match at www.virtualinvestorconferences.com.
Contemporary Corporate Highlights
- Report quarterly revenues of $12.7 million in This autumn-22, up 274% over This autumn-21
- Report revenues in 2022 of $27.7 million, up 105% over 2021
- Report revenues forecasted in Q1-23
- In way over $60 million raised in financings in 2022
Article content material
Commercial 3
Article content material
About Valeo Pharma
Valeo Pharma is a Canadian pharmaceutical corporate devoted to the commercialization of cutting edge prescription merchandise in Canada with a focal point on Respiration/Hypersensitivity, Ophthalmology and Health center Area of expertise Merchandise. Headquartered in Kirkland, Quebec Valeo Pharma has all of the vital functions and a whole infrastructure to sign in and organize its rising product portfolio via all levels of commercialization. For more info, please discuss with www.valeopharma.com and apply us on LinkedIn and Twitter.
About Digital Investor Meetings®
Digital Investor Meetings (VIC) is the main proprietary investor convention collection that gives an interactive discussion board for publicly traded firms to seamlessly provide without delay to traders.
Commercial 4
Article content material
Offering a real-time investor engagement resolution, VIC is in particular designed to provide firms extra environment friendly investor get admission to. Replicating the parts of an on-site investor convention, VIC provides firms enhanced functions to hook up with traders, agenda centered one-on-one conferences and fortify their displays with dynamic video content material. Accelerating the following degree of investor engagement, Digital Investor Meetings delivers main investor communications to an international community of retail and institutional traders.
CONTACTS:
Valeo Pharma
Frederic Dumais
Director, Communications and Investor Members of the family
514-693-8847
dumais@valeopharma.com
Digital Investor Meetings
John M. Viglotti
SVP Company Services and products, Investor Get right of entry to
OTC Markets Staff
(212) 220-2221
johnv@otcmarkets.com
Feedback
Postmedia is dedicated to keeping up a full of life however civil discussion board for dialogue and inspire all readers to proportion their perspectives on our articles. Feedback might take as much as an hour for moderation sooner than showing at the website. We ask you to stay your feedback related and respectful. We have now enabled e mail notifications—you’re going to now obtain an e mail when you obtain a answer in your remark, there’s an replace to a remark thread you apply or if a person you apply feedback. Seek advice from our Group Pointers for more info and main points on how one can alter your e mail settings.
Sign up for the Dialog